Cargando…

Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase I clinical trial in early-stage pancreatic ductal adenocarcinoma

BACKGROUND: Recent reports of the utilisation of pyrvinium pamoate (PP), an FDA-approved anti-helminth, have shown that it inhibits pancreatic ductal adenocarcinoma (PDAC) cell growth and proliferation in-vitro and in-vivo in preclinical models. Here, we report about an ongoing phase I open-label, s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ponzini, Francesca M, Schultz, Christopher W, Leiby, Benjamin E, Cannaday, Shawnna, Yeo, T, Posey, James, Bowne, Wilbur B, Yeo, Charles, Brody, Jonathan R, Lavu, Harish, Nevler, Avinoam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582846/ https://www.ncbi.nlm.nih.gov/pubmed/37848297 http://dx.doi.org/10.1136/bmjopen-2023-073839

Ejemplares similares

Pyrvinium Pamoate: Past, Present, and Future as an Anti-Cancer Drug
por: Schultz, Christopher W., et al.
Publicado: (2022)

Association of Smoking and Respiratory Disease History with Pancreatic Pathologies Requiring Surgical Resection
por: Ream, Carolyn, et al.
Publicado: (2023)

Rare occurrence of pseudomyxoma peritonei (PMP) syndrome arising from a malignant transformed ovarian primary mature cystic teratoma treated by cytoreductive surgery and HIPEC: a case report
por: Ponzini, Francesca, et al.
Publicado: (2022)

Reprofiling a classical anthelmintic, pyrvinium pamoate, as an anti-cancer drug targeting mitochondrial respiration
por: Ishii, Isao, et al.
Publicado: (2012)

Anthelmintic pyrvinium pamoate blocks Wnt/β-catenin and induces apoptosis in multiple myeloma cells
por: Xu, Fang, et al.
Publicado: (2020)

Chronic Obstructive Pulmonary Disease Is Associated with Worse Oncologic Outcomes in Early-Stage Resected Pancreatic and Periampullary Cancers
por: Huang, Rachel, et al.
Publicado: (2023)

Pyrvinium Pamoate and Structural Analogs Are Early Macrofilaricide Leads
por: Gunderson, Emma L., et al.
Publicado: (2022)

An Anthelmintic Drug, Pyrvinium Pamoate, Thwarts Fibrosis and Ameliorates Myocardial Contractile Dysfunction in a Mouse Model of Myocardial Infarction
por: Murakoshi, Motoaki, et al.
Publicado: (2013)

The Antihelmintic Drug Pyrvinium Pamoate Targets Aggressive Breast Cancer
por: Xu, Wei, et al.
Publicado: (2013)

Repurposing the FDA-Approved Pinworm Drug Pyrvinium as a Novel Chemotherapeutic Agent for Intestinal Polyposis
por: Li, Bin, et al.
Publicado: (2014)

Pyrvinium pamoate can overcome artemisinin’s resistance in anaplastic thyroid cancer
por: Li, Yitian
Publicado: (2021)

Synergistic Effect of Pyrvinium Pamoate and Azoles Against Aspergillus fumigatus in vitro and in vivo
por: Sun, Yi, et al.
Publicado: (2020)

Synergistic effect of pyrvinium pamoate and posaconazole against Cryptococcus neoformans in vitro and in vivo
por: Li, Yali, et al.
Publicado: (2022)

Integrative analysis reveals therapeutic potential of pyrvinium pamoate in Merkel cell carcinoma
por: Yang, Jiawen, et al.
Publicado: (2023)

A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,3-Dioxygenase-2
por: Nevler, Avinoam, et al.
Publicado: (2018)

Salvage endoscopic ultrasound-guided gastrojejunostomy as a bridge to definitive surgical therapy for duodenal adenocarcinoma presenting with duodenal stent obstruction
por: Yu, Tiffany Z., et al.
Publicado: (2023)

Pyrvinium pamoate changes alternative splicing of the serotonin receptor 2C by influencing its RNA structure
por: Shen, Manli, et al.
Publicado: (2013)

In vitro and in vivo Study of Antifungal Effect of Pyrvinium Pamoate Alone and in Combination With Azoles Against Exophiala dermatitidis
por: Sun, Yi, et al.
Publicado: (2020)

Identification of pyrvinium pamoate as an anti-tuberculosis agent in vitro and in vivo by SOSA approach amongst known drugs
por: Guan, Qing, et al.
Publicado: (2020)

Pyrvinium pamoate inhibits cell proliferation through ROS-mediated AKT-dependent signaling pathway in colorectal cancer
por: Zheng, Wenqian, et al.
Publicado: (2021)

P007 Fumaric reductase analog regulates sensitivity of pyrvinium pamoate and voriconazoole against Exophiala Dermatiti dis
por: Li, Xiaotong, et al.
Publicado: (2022)

Precious Data: Interim Report from the Jefferson Pancreas Tumor Registry
por: Yeo, Theresa P., et al.
Publicado: (2018)

Surgeon-Led Imaging Review for Patients with Periampullary Disease: An Important Aspect of the Preoperative Consultation
por: Latona, Jessica A., et al.
Publicado: (2018)

Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction
por: Kittirat, Yingpinyapat, et al.
Publicado: (2021)

Effect of the anti-parasitic compounds pyrvinium pamoate and artemisinin in enzymatic and culture assays: Data on the search for new anti-echinococcal drugs
por: Enkai, Shigehiro, et al.
Publicado: (2020)

High-throughput drug screening reveals Pyrvinium pamoate as effective candidate against pediatric MLL-rearranged acute myeloid leukemia
por: Wander, Priscilla, et al.
Publicado: (2021)

Pyrvinium pamoate regulates MGMT expression through suppressing the Wnt/β-catenin signaling pathway to enhance the glioblastoma sensitivity to temozolomide
por: Li, Haisong, et al.
Publicado: (2021)

Genetic Drivers of Pancreatic Cancer Are Identical Between the Primary Tumor and a Secondary Lesion in a Long-Term (>5 Years) Survivor After a Whipple Procedure
por: Bauer, Tyler M., et al.
Publicado: (2018)

Deciphering the Role of Pyrvinium Pamoate in the Generation of Integrated Stress Response and Modulation of Mitochondrial Function in Myeloid Leukemia Cells through Transcriptome Analysis
por: Fu, Yu-Hsuan, et al.
Publicado: (2021)

The FDA-Approved Drug Pyrvinium Selectively Targets ER(+) Breast Cancer Cells with High INPP4B Expression
por: Rodgers, Samuel J., et al.
Publicado: (2022)

Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy
por: Zhang, Chongyuan, et al.
Publicado: (2017)

The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer
por: Florio, Rosalba, et al.
Publicado: (2019)

Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells
por: Hou, Zhi-Jie, et al.
Publicado: (2015)

Repurposing FDA-approved drugs for anti-aging therapies
por: Snell, Terry W., et al.
Publicado: (2016)

A Persistent Solid Pseudopapillary Tumor of the Pancreas: Case Report and Brief Literature Review
por: Zhang, Jin Bao, et al.
Publicado: (2015)

Microencapsulated octreotide pamoate in advanced gastrointestinal and pancreatic cancer: a phase I study.
por: Helle, S. I., et al.
Publicado: (1998)

Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents
por: Shi, Wenjie, et al.
Publicado: (2022)

Identification of Pyrvinium, an Anthelmintic Drug, as a Novel Anti-Adipogenic Compound Based on the Gene Expression Microarray and Connectivity Map
por: Wang, Zonggui, et al.
Publicado: (2019)

Repurposing of FDA-approved drugs against cancer – focus on metastasis
por: Ozsvári, Béla, et al.
Publicado: (2016)

Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle
por: Huang, Yue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u5nq8prm14ctc6qkkk062m2bil